Gaps in US Psychedelic Policy and How to Close Them

This Viewpoint discusses how to fill policy gaps surrounding the use of psychedelics to treat mental health and substance use conditions, should they be approved by the US Food and Drug Administration.

from JAMA Health Forum New Online https://ift.tt/XkH0g97